STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
On December 6, 2013, Moberg Pharma (STO:MOB) announced the acquisition of three Over-The-Counter brands in the U.S. from Bayer HealthCare, LLC. The acquisition has now been completed. The purchase price amounted to 4.8 MUSD.
The acquired portfolio includes Domeboro®, a topical astringent used for relieving itch and minor skin irritations; Vanquish®, an internal analgesic; and Fergon®, an iron supplement. The brands are sold through Moberg’s current channel, primarily in chain drugstores and mass retailers, such as Walmart.
Help employers find you! Check out all the jobs and post your resume.
